Cerus CERS
NASDAQ CERS
$2.51 -0.03 (-1.18%)
As of: Sep 9, 2026 · 3:59 PM EDT

Cerus (CERS) Receivables - Other (2018 - 2021)

Cerus' (CERS) quarterly Receivables - Other came in at $2.7 million in Q3 2021, down 53.09% quarter-over-quarter from $5.7 million in Q2 2021.

Analysis

Cerus (CERS) Receivables - Other (2018 - 2021) Analysis & Trends

Cerus has disclosed Receivables - Other across 3 years of filings, most recently posting $2.7 million for Q3 2021.

  • In Q3 2021, Receivables - Other changed N/A year-over-year to $2.7 million; the TTM figure through Sep 2021 stood at $2.7 million (changed N/A YoY), while the FY2020 annual figure was $2.4 million, changed N/A from the prior year.
  • Receivables - Other came in at $2.7 million for Q3 2021 at Cerus, down from $5.7 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $5.7 million in Q2 2021 to a low of $1.2 million in Q4 2018.
  • Average Receivables - Other over 3 years is $3.0 million, with a median of $2.7 million recorded in 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn
10 Cerus 504.42 Mn 448.16 Mn 29.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 2.66 Mn
Jun 30, 2021 5.68 Mn
Mar 31, 2021 3.30 Mn
Dec 31, 2020 2.38 Mn
Dec 31, 2018 1.20 Mn